BeiGene, Ltd. Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BeiGene, Ltd. for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 461,075 | |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 12.34 | 27,027 | 333,513 | 283,153 | |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 193.56 | 100 | 19,356 | 0 | 100 to 0 (-100.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 192.72 | 198 | 38,158 | 100 | 298 to 100 (-66.44 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 191.37 | 500 | 95,685 | 298 | 798 to 298 (-62.66 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 188.95 | 402 | 75,959 | 798 | 1.2 K to 798 (-33.50 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 187.91 | 300 | 56,373 | 1,200 | 1.5 K to 1.2 K (-20.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 192.46 | 435 | 83,720 | 0 | 435 to 0 (-100.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 200.30 | 700 | 140,208 | 0 | 700 to 0 (-100.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 200.29 | 700 | 140,204 | 700 | 1.4 K to 700 (-50.00 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 200.27 | 679 | 135,985 | 1,400 | 2.1 K to 1.4 K (-32.66 %) |
| Jun 30 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 160.40 | 2,079 | 333,472 | 2,079 | 0 to 2.1 K |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 189.42 | 1,725 | 326,745 | 0 | 1.7 K to 0 (-100.00 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 188.20 | 3,800 | 715,163 | 1,725 | 5.5 K to 1.7 K (-68.78 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 187.10 | 4,115 | 769,914 | 5,525 | 9.6 K to 5.5 K (-42.69 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 186.11 | 4,741 | 882,334 | 9,640 | 14.4 K to 9.6 K (-32.97 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 188.43 | 410 | 77,258 | 14,381 | 14.8 K to 14.4 K (-2.77 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 187.46 | 7,438 | 1,394,335 | 14,791 | 22.2 K to 14.8 K (-33.46 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 186.63 | 4,922 | 918,569 | 22,229 | 27.2 K to 22.2 K (-18.13 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 185.54 | 1,610 | 298,712 | 27,151 | 28.8 K to 27.2 K (-5.60 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 184.56 | 690 | 127,348 | 28,761 | 29.5 K to 28.8 K (-2.34 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 183.72 | 3,095 | 568,601 | 29,451 | 32.5 K to 29.5 K (-9.51 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 182.78 | 3,714 | 678,839 | 32,546 | 36.3 K to 32.5 K (-10.24 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 181.79 | 1,772 | 322,138 | 36,260 | 38 K to 36.3 K (-4.66 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 180.50 | 800 | 144,401 | 38,032 | 38.8 K to 38 K (-2.06 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 179.59 | 900 | 161,626 | 38,832 | 39.7 K to 38.8 K (-2.27 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 187.36 | 700 | 131,154 | 0 | 700 to 0 (-100.00 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 186.62 | 3,455 | 644,756 | 700 | 4.2 K to 700 (-83.15 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 185.58 | 1,845 | 342,388 | 4,155 | 6 K to 4.2 K (-30.75 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 183.38 | 180 | 33,009 | 0 | 180 to 0 (-100.00 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 182.52 | 800 | 146,016 | 180 | 980 to 180 (-81.63 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 181.52 | 2,220 | 402,982 | 980 | 3.2 K to 980 (-69.37 %) |
| Jun 24 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 180.37 | 1,800 | 324,666 | 3,200 | 5 K to 3.2 K (-36.00 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 13.42 | 90,766 | 1,218,080 | 90,766 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | HOOPER ANTHONY C | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | su Jingshyh S | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | A | 13.42 | 273,286 | 3,667,498 | 273,286 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Grant | A | 0.00 | 48,438 | 0 | 331,902 | 283.5 K to 331.9 K (+17.09 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | A | 13.42 | 315,341 | 4,231,876 | 315,341 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Grant | A | 0.00 | 55,887 | 0 | 172,315 | 116.4 K to 172.3 K (+48.00 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Option Exercise | A | 13.42 | 756,821 | 10,156,538 | 756,821 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Grant | A | 0.00 | 134,147 | 0 | 1,514,562 | 1.4 M to 1.5 M (+9.72 %) |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Option Exercise | A | 13.42 | 1,821,976 | 24,450,918 | 1,821,976 | |
| Jun 12 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 175.07 | 900 | 157,563 | 0 | 900 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 170.84 | 453 | 77,391 | 0 | 453 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 171.98 | 475 | 81,691 | 0 | 475 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 171.20 | 1,125 | 192,605 | 475 | 1.6 K to 475 (-70.31 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 170.02 | 1,200 | 204,022 | 1,600 | 2.8 K to 1.6 K (-42.86 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 170.84 | 631 | 107,800 | 0 | 631 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 172.46 | 200 | 34,492 | 0 | 200 to 0 (-100.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 171.43 | 2,300 | 394,277 | 200 | 2.5 K to 200 (-92.00 %) |
| Jun 10 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 170.48 | 3,500 | 596,686 | 2,500 | 6 K to 2.5 K (-58.33 %) |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 480,575 | |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 165.12 | 431 | 71,168 | 0 | 431 to 0 (-100.00 %) |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 163.97 | 569 | 93,300 | 431 | 1,000 to 431 (-56.90 %) |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 162.63 | 500 | 81,316 | 1,000 | 1.5 K to 1,000 (-33.33 %) |
| Jun 02 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |